NALP3 Polyclonal Antibody

$THP-1 (H) cells were treated with or without LPS (10 \u00b5g\/ml) for 8 h, 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with NALP3 polyclonal antibody, unconjugated (bs-25913R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

THP-1 (H) cells were treated with or without LPS (10 \u00b5g\/ml) for 8 h, 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with NALP3 polyclonal antibody, unconjugated (bs-25913R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

Reactivity

Human

Predicted Reactivity

Mouse
Rat

Overview
Catalog #	bs-25913r
Product Name	NALP3 Polyclonal Antibody
Applications	WB
Reactivity	Human
Predicted Reactivity	Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human NALP3
Clonality	Polyclonal
Isotype	IgG
Concentration	1mg/ml
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	114548
Swiss Prot	Q96P20
Subcellular location	Cytoplasm
Synonyms	AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1; AII/AVP; Mmig1; NLRP3_HUMAN; NLRP3; Angiotensin/vasopressin receptor AII/AVP-like; Caterpiller protein 1.1 (CLR1.1); Cold-induced autoinflammatory syndrome 1 pr
Application Dilution
WB	=1:500-2000